Pharmaceutical Market in India by 2020 - IKON Marketing Consultants

Pharmaceutical Market in Indiaby 2020: A Healthy DecadeIKON Pharmaceutical Consulting Practice

About this ReportThis report begins with the current scenario of Pharmaceutical market in India withcurrent market size and structure, market drivers, challenges and competitivelandscape. Chapter 2 highlights factors leading India's emergence as a major globalplayer along with the global pharma market overview. The chapter 3 throws light onhow the current decade going to remain healthy for the Indian pharma Industryfollowed by Chapter4 regulatory environment stating various laws and regulationeffecting Indian pharma Industry. The report gives overall feel of how by 2020 theIndian pharma industry is going to grow healthy and going to make its existencenoticeable in global pharma Industry.The Indian pharmaceutical market is highly regulated and fragmented, dominated byprivate Indian companies. Currently the domestic Indian Pharmaceutical market isvalued at US$14.30 billion growing at a healthy double digit CAGR of 13% since 2005-06. The major growth contributors are strong Indian demographics with robusteconomic YOY growth, increase in affordability of medicines, an increased percentage ofdisposable income being spent on healthcare and increased penetration of healthinsurance. Also from the government initiatives side, the government has made publichealthcare one of its top priorities by launching policies and programs aimed at makinghealthcare more affordable and accessible, especially in rural markets.The global pharma market is expected to grow at 7% to 8% CAGR over the next fiveyears, reaching an anticipated US$ 1.7 trillion in 2020, India is going to rank among top10 global player by 2015 itself. Looking at the immense potential Indian Pharmaceuticalindustry have, IKON estimates that the current decade will be going to change theprescription in Indian Pharmaceutical industry. India will emerge as a leading globalplayer holding the rank among top five major global markets by 2020.Beneficial to:Pharma Companies, Investors and Venture Capitalists, Industry Analysts & Consultants,Corporate and Entrepreneurs, Industry association, Education and GovernmentInstituteswww.ikonmarket.com pg. 2

CHAPTER: 2 INDIA: Emerging Major Global Player2.1 Global Pharmaceutical Market: at a glance2.1.1 Overview2.1.2 Top 20 global therapeutic areas2.1.3 Key Global Trends2.2 India’s emergence as major global player2.2.1 India: A robust economy2.2.2 India: Among top 10 major global players by 20152.2.3 India: A Low cost global outsourcing hub2.2.4 India: Significant Share in World ExportCHAPTER: 3 2020: A Healthy Decade for Indian Pharmaceutical Industry3.1 A decade of Growth: 20203.1.1 Market size by 20203.2 Factors will drive growth in current decade3.2.1 Largest Domestic Market3.2.2 Spending on Drugs & Pharmaceuticals3.2.3 Penetration of Health Insurance3.2.4 Booming Indian Healthcare Industry3.2.5 Shifting pattern of diseases3.2.6 New emerging sector opportunities3.2.7 Rise of Tire ii, iii and rural areas3.2.8 Global Future Market Segments3.2.9 Rise of Diseases as an Epidemic in IndiaCHAPTER: 4 Regulatory EnvironmentRESEARCH METHODOLOGYABOUT IKONwww.ikonmarket.com pg. 4

List of Figures:Figure 1: Product SegmentsFigure 2: Sector contribution in Industry turnoverFigure 3: Pharmaceutical market by products/serviceFigure 4: Pharmaceutical market by TherapeuticsFigure 5: Indian Pharmaceutical MarketFigure 6: International Trade of Drugs & Pharmaceuticals in IndiaFigure 7: Share of international trade industry turnoverFigure 8: India real GDP growth rateFigure 9: India monthly disposable incomeFigure 10: US-FDA approved plants in IndiaFigure 11: India advantage for outsourcing opportunitiesFigure 12: Global Pharmaceutical MarketFigure 13: GDP growth rate in emerging economiesFigure 14: Top 10 global pharma markets by 2015Figure 15: Top 15 major export playersFigure 16: Indian pharma industry by 2020Figure 17: India population in coming decadesFigure 18: Heath insurance coverage in IndiaFigure 19: India Health insurance penetration in current decadeFigure 20: Hospital market in IndiaList of Tables:Table 1: Patent Application in Indian Pharma sectorTable2: Top 10 Major Indian Applicants for patents from Pharmaceutical industry(2009-10)Table 3: Key recent M&ATable 4: The leading pharmaceutical market players in IndiaTable 5: Top 10 player’s sales turnover and market share (2009-10)Table 6: Top 20 global therapeutic areasPUBLISHED IN: 2011 PAGES: 50Delivery: Soft Copy (PDF file) within 1-2 working daysTo buy this report, email us at- research@ikonmarket.com OR Call at +91-281-2483151www.ikonmarket.com pg. 5

ABOUT IKONPHARMACEUTICALS CONSULTING PRACTICE at IKON:IKON’s Pharmaceutical & Biotechnology practice helps Indian & foreignpharmaceutical companies, biotech companies, OTC productmanufactures, clinical trial research companies with MarketingStrategy, Market opportunity assessment studies, India entry strategyby Joint ventures, M&A and technology transfers.Our Pharmaceutical & Biotechnology Marketing Consulting practicecovers,• Pharmaceuticals marketing strategy• Implementation support for Pharmaceutical Marketing strategyand plan• International Marketing of Pharmaceutical & BiotechnologyProducts• Pharmaceutical & Biotechnology Market Research in India andGlobal Market• Branding of Pharmaceutical & Biotechnology products/companies• India Entry StrategyIKON’s Pharmaceutical & Biotechnology expert team consists ofPharmaceutical experts, Doctors, Professionals from biotechnologyfield helping clients to achieve their goals and objectives in effectivemanner without adversely affecting the social, human & naturalenvironment.CONTACT:IKON MARKETING CONSULTANTSHead Office: 130- J P Tower, Tagore Road, Rajkot – 360 002,Gujarat/INDIAPh: +91-281-2483151/3012211 Fax: +91-281-2464814Web: www.ikonmarket.com Email: info@ikonmarket.comwww.ikonmarket.com pg. 6